title: Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
authors.forename: Müzeyyen Mamal
authors.initials: MM
authors.lastname: Torun
authors.forename: Hrisi
authors.initials: H
authors.lastname: Bahar
authors.forename: Mehmet
authors.initials: M
authors.lastname: Demirci
authors.forename: Kemal
authors.initials: K
authors.lastname: Altaş
authors.forename: Yaşar
authors.initials: Y
authors.lastname: Bağdatli
authors.forename: Bekir
authors.initials: B
authors.lastname: Kocazeybek
authors.forename: Maria
authors.initials: M
authors.lastname: Kapi
authors.forename: Keiichi
authors.initials: K
authors.lastname: Hiramatsu
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003234:Conjunctivitis, Bacterial / Q000382:microbiology; D003625:Data Collection; D017719:Diabetic Foot / Q000382:microbiology; D005260:Female; D006785:Hospitals, University; D006801:Humans; D008297:Male; D008712:Methicillin / Q000494:pharmacology*; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D012008:Recurrence; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects*; D014421:Turkey; D014640:Vancomycin / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D008712:Methicillin